BiomeBank has raised $10.7m to fast-track Crohn’s disease treatment
ADELAIDE: BiomeBank has raised $10.65m with the Adelaide-based biotechnology company to use the money to… read more
Cochlear acquisition deal sparks ACCC competition concerns
MELBOURNE: Cochlear’s proposed $170 million acquisition of a Danish hearing loss device maker is in… read more
Healius dives as Covid-19 boom times end for pathology giants
MELBOURNE: Healius shares have dived more than 10 per cent after it revealed its taxpayer-funded… read more
